Lifecycle Approach to Global Stability Testing Compliance
Pharmaceutical stability testing is not a one-time activity restricted to pre-approval stages. Instead, it follows a comprehensive lifecycle approach—extending from early development through post-approval surveillance—to ensure consistent product quality over time. This regulatory-focused article explores how companies can align their global stability testing efforts with lifecycle principles, complying with agencies such as USFDA, EMA, WHO,…
Read More “Lifecycle Approach to Global Stability Testing Compliance” »
